| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nelly Ziade | Q91392821 |
| P2093 | author name string | Rajaie Namas | |
| Bassel El Zorkany | |||
| Mohamed Bedaiwi | |||
| Haytham Mohamed Ahmed | |||
| Waleed Husain | |||
| Yaser Mustafa Ali | |||
| P2860 | cites work | Consanguinity and genetic diseases in North Africa and immigrants to Europe | Q26852011 |
| HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps | Q32173857 | ||
| Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 | ||
| Prevalence of HLA-B27 in Patients with Ankylosing Spondylitis in Qatar | Q35884810 | ||
| Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care | Q35940404 | ||
| The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? | Q36092954 | ||
| Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns | Q36302777 | ||
| Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation. | Q36419077 | ||
| The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study | Q36976429 | ||
| Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages. | Q37312528 | ||
| Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis | Q37612248 | ||
| Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis | Q38682092 | ||
| Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force | Q38690324 | ||
| Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus | Q38711954 | ||
| Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia | Q38812546 | ||
| Axial spondyloarthritis. | Q39098003 | ||
| Validation of the Tunisian versions of Bath Ankylosing Spondylitis Functional Index (BASFI) and Disease Activity Index (BASDAI). | Q39125670 | ||
| Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis. | Q39410595 | ||
| Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population | Q39513524 | ||
| Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey | Q39826019 | ||
| WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. | Q39845669 | ||
| Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study | Q40405924 | ||
| Rheumatology in the Middle East in 2017: clinical challenges and research | Q42333094 | ||
| 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis | Q48049806 | ||
| Interethnic Variations and Clinical Features of Spondyloarthropathies in a Middle Eastern Country | Q49756328 | ||
| Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? | Q51804835 | ||
| The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. | Q51848130 | ||
| Knowledge and attitudes of primary health care physicians towards complementary and alternative medicine in the Riyadh region, Saudi Arabia. | Q53648702 | ||
| Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 Prevalence | Q64118193 | ||
| The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study. | Q64946662 | ||
| Profile of ankylosing spondylitis in Saudi Arabia | Q71502447 | ||
| The demographic and clinical spectrum of Arab versus Asian patients with ankylosing spondylitis in the UAE | Q74445273 | ||
| Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East | Q84823754 | ||
| Diagnostic delay in axial spondyloarthritis: A cross-sectional study of 432 patients | Q87983888 | ||
| High Accuracy and Significant Savings Using Tag-SNP Genotyping to Determine HLA-B*27 Status | Q88216447 | ||
| HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study | Q91392825 | ||
| 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | Q92764961 | ||
| Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study | Q94591396 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P577 | publication date | 2020-09-15 | |
| 2020-11-01 | |||
| P1433 | published in | International Journal of Rheumatic Diseases | Q15764244 |
| P1476 | title | The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: From diagnosis to management |
Search more.